Net profit of Jenburkt Pharmaceuticals rose 4.99% to Rs 7.79 crore in the quarter ended June 2025 as against Rs 7.42 crore during the previous quarter ended June 2024. Sales rose 9.19% to Rs 35.53 crore in the quarter ended June 2025 as against Rs 32.54 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 35.53 | 32.54 | 9 |
| OPM % | 25.19 | 28.55 | - |
| PBDT | 10.90 | 10.59 | 3 |
| PBT | 10.18 | 10.07 | 1 |
| NP | 7.79 | 7.42 | 5 |